These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 35371003)
1. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome. Ringdén O; Moll G; Gustafsson B; Sadeghi B Front Immunol; 2022; 13():839844. PubMed ID: 35371003 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease. Ringdén O; Gustafsson B; Sadeghi B Front Immunol; 2020; 11():567210. PubMed ID: 33193339 [TBL] [Abstract][Full Text] [Related]
3. Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease. Ringdén O; Sadeghi B Stem Cells; 2024 Apr; 42(4):291-300. PubMed ID: 38204331 [TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review. Sadeghi B; Ringdén O; Gustafsson B; Castegren M Front Immunol; 2022; 13():963445. PubMed ID: 36426365 [TBL] [Abstract][Full Text] [Related]
5. Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease. Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B Stem Cells Transl Med; 2018 Apr; 7(4):325-331. PubMed ID: 29533533 [TBL] [Abstract][Full Text] [Related]
6. Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease. Stenger E; Giver CR; Langston A; Kota D; Das PK; Chinnadurai R; Galipeau J; Waller EK; Qayed M Front Immunol; 2022; 13():959658. PubMed ID: 36189324 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model. Grégoire C; Ritacco C; Hannon M; Seidel L; Delens L; Belle L; Dubois S; Vériter S; Lechanteur C; Briquet A; Servais S; Ehx G; Beguin Y; Baron F Front Immunol; 2019; 10():619. PubMed ID: 31001253 [TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series. Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427 [TBL] [Abstract][Full Text] [Related]
10. Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment. Aghayan HR; Salimian F; Abedini A; Fattah Ghazi S; Yunesian M; Alavi-Moghadam S; Makarem J; Majidzadeh-A K; Hatamkhani A; Moghri M; Danesh A; Haddad-Marandi MR; Sanati H; Abbasvandi F; Arjmand B; Azimi P; Ghavamzadeh A; Sarrami-Forooshani R Stem Cell Res Ther; 2022 Jul; 13(1):365. PubMed ID: 35902979 [TBL] [Abstract][Full Text] [Related]
11. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease. Zhao L; Chen S; Yang P; Cao H; Li L Stem Cell Res Ther; 2019 Jun; 10(1):182. PubMed ID: 31227011 [TBL] [Abstract][Full Text] [Related]
12. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant? Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502 [TBL] [Abstract][Full Text] [Related]
13. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model. Li ZY; Wang CQ; Lu G; Pan XY; Xu KL Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072 [TBL] [Abstract][Full Text] [Related]
14. Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdc Hansen M; Stahl L; Heider A; Hilger N; Sack U; Kirschner A; Cross M; Fricke S Transplant Cell Ther; 2021 Aug; 27(8):658.e1-658.e10. PubMed ID: 33964513 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Keklik M; Deveci B; Celik S; Deniz K; Gonen ZB; Zararsiz G; Saba R; Akyol G; Ozkul Y; Kaynar L; Keklik E; Unal A; Cetin M; Jones OY Ann Hematol; 2023 Jun; 102(6):1537-1547. PubMed ID: 37067556 [TBL] [Abstract][Full Text] [Related]
16. Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome? Hamdan H; Hashmi SK; Lazarus H; Gale RP; Qu W; El Fakih R Blood Rev; 2021 Mar; 46():100742. PubMed ID: 32854985 [TBL] [Abstract][Full Text] [Related]
17. Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD? Introna M; Golay J Front Immunol; 2020; 11():609063. PubMed ID: 33362797 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Markov A; Thangavelu L; Aravindhan S; Zekiy AO; Jarahian M; Chartrand MS; Pathak Y; Marofi F; Shamlou S; Hassanzadeh A Stem Cell Res Ther; 2021 Mar; 12(1):192. PubMed ID: 33736695 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Follow-Up After the Application of Mesenchymal Stromal Cells in Children and Adolescents with Steroid-Refractory Graft-Versus-Host Disease. Döring M; Cabanillas Stanchi KM; Lenglinger K; Treuner C; Gieseke F; Erbacher A; Mezger M; Vaegler M; Schlegel PG; Greil J; Bettoni da Cunha Riehm C; Faul C; Schumm M; Lang P; Handgretinger R; Müller I Stem Cells Dev; 2021 Mar; 30(5):234-246. PubMed ID: 33446053 [TBL] [Abstract][Full Text] [Related]
20. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]